Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuki Sawamoto

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|August 28, 2019
Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine ModelKazuki Sawamoto, Shunji Tomatsu
Gastroenterology Research and Practice|June 6, 2012
Disposition kinetics of taxanes in peritoneal disseminationKen'ichi Miyamoto, Tsutomu Shimada, Kazuki Sawamoto, et al.
Diabetology International|January 24, 2024
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activationSuratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, et al.
International Journal of Molecular Sciences|May 17, 2020
Evading the AAV Immune Response in MucopolysaccharidosesMatthew Piechnik, Kazuki Sawamoto, Hidenori Ohnishi, et al.
Journal of Inherited Metabolic Disease|November 19, 2015
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?Shunji Tomatsu, Isabella Azario, Kazuki Sawamoto, et al.
Molecular Genetics and Metabolism|January 4, 2018
Gene therapy for MucopolysaccharidosesKazuki Sawamoto, Hui-Hsuan Chen, Carlos J Alméciga-Díaz, et al.
Drug Metabolism and Pharmacokinetics|March 28, 2014
Mechanisms of lower maintenance dose of tacrolimus in obese patientsKazuki Sawamoto, Tran T Huong, Natsumi Sugimoto, et al.
Molecular Therapy. Methods & Clinical Development|June 25, 2020
Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine ModelKazuki Sawamoto, Subha Karumuthil-Melethil, Shaukat Khan, et al.
Human Gene Therapy|October 25, 2024
Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA MiceAngélica María Herreño-Pachón, Kazuki Sawamoto, Molly Stapleton, et al.
International Journal of Molecular Sciences|February 28, 2020
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and ManagementKazuki Sawamoto, José Víctor Álvarez González, Matthew Piechnik, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|August 28, 2019
Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine ModelKazuki Sawamoto, Shunji Tomatsu
Gastroenterology Research and Practice|June 6, 2012
Disposition kinetics of taxanes in peritoneal disseminationKen'ichi Miyamoto, Tsutomu Shimada, Kazuki Sawamoto, et al.
Diabetology International|January 24, 2024
A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activationSuratsawadee Promsuwan, Kazuki Sawamoto, Liang Xu, et al.
International Journal of Molecular Sciences|May 17, 2020
Evading the AAV Immune Response in MucopolysaccharidosesMatthew Piechnik, Kazuki Sawamoto, Hidenori Ohnishi, et al.
Journal of Inherited Metabolic Disease|November 19, 2015
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?Shunji Tomatsu, Isabella Azario, Kazuki Sawamoto, et al.
Molecular Genetics and Metabolism|January 4, 2018
Gene therapy for MucopolysaccharidosesKazuki Sawamoto, Hui-Hsuan Chen, Carlos J Alméciga-Díaz, et al.
Drug Metabolism and Pharmacokinetics|March 28, 2014
Mechanisms of lower maintenance dose of tacrolimus in obese patientsKazuki Sawamoto, Tran T Huong, Natsumi Sugimoto, et al.
Molecular Therapy. Methods & Clinical Development|June 25, 2020
Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine ModelKazuki Sawamoto, Subha Karumuthil-Melethil, Shaukat Khan, et al.
Human Gene Therapy|October 25, 2024
Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA MiceAngélica María Herreño-Pachón, Kazuki Sawamoto, Molly Stapleton, et al.
International Journal of Molecular Sciences|February 28, 2020
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and ManagementKazuki Sawamoto, José Víctor Álvarez González, Matthew Piechnik, et al.
Pageof 4